|
1
|
Eikelboom JW, Karthikeyan G, Fagel N and
Hirsh J: American Association of Orthopedic Surgeons and American
College of Chest Physicians guidelines for venous thromboembolism
prevention in hip and knee arthroplasty differ: what are the
implications for clinicians and patients? Chest. 135:513–520. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lee S, Hwang JI, Kim Y, Yoon PW, Ahn J and
Yoo JJ: Venous thromboembolism following hip and knee replacement
arthroplasty in Korea: a nationwide study based on claims registry.
J Korean Med Sci. 31:80–88. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kurtz S, Ong K, Lau E, Mowat F and Halpern
M: Projections of primary and revision hip and knee arthroplasty in
the United States from 2005 to 2030. J Bone Joint Surg Am.
89:780–785. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Selby R and Geerts W: Prevention of venous
thromboembolism: Consensus, controversies, and challenges.
Hematology (Am Soc Hematol Educ Program). 2009:286–292. 2009.
|
|
5
|
Paolucci F, Clavies MC, Donat F and
Necciari J: Fondaparinux sodium mechanism of action: Identification
of specific binding to purified and human plasma-derived proteins.
Clin Pharmacokinet. 41(Suppl 2): 11–18. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Keam SJ and Goa KL: Fondaparinux sodium.
Drugs. 62:1673–1685, 1686–1687. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Geerts WH, Heit JA, Clagett GP, Pineo GF,
Colwell CW, Anderson FA and Wheeler HB: Prevention of venous
thromboembolism. Chest. 119(Suppl 1): 132S–175S. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ibbotson T and Goa KL: Enoxaparin: An
update of its clinical use in the management of acute coronary
syndromes. Drugs. 62:1407–1430. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Turpie AG, Eriksson BI, Lassen MR and
Bauer KA: Fondaparinux, the first selective factor Xa inhibitor.
Curr Opin Hematol. 10:327–332. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bergqvist D: Review of fondaparinux sodium
injection for the prevention of venous thromboembolism in patients
undergoing surgery. Vasc Health Risk Manag. 2:365–370. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lassen MR, Bauer KA, Eriksson BI and
Turpie AG: European Pentasaccharide Elective Surgery Study
(EPHESUS) Steering Committee: Postoperative fondaparinux versus
preoperative enoxaparin for prevention of venous thromboembolism in
elective hip-replacement surgery: a randomised double-blind
comparison. Lancet. 359:1715–1720. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Turpie AG, Bauer KA, Eriksson BI and
Lassen MR: PENTATHALON 2000 Study Steering Committee: Postoperative
fondaparinux versus postoperative enoxaparin for prevention of
venous thromboembolism after elective hip-replacement surgery: a
randomised double-blind trial. Lancet. 359:1721–1726. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yokote R, Matsubara M, Hirasawa N, Hagio
S, Ishii K and Takata C: Is routine chemical thromboprophylaxis
after total hip replacement really necessary in a Japanese
population? J Bone Joint Surg Br. 93:251–256. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Migita K, Bito S, Nakamura M, Miyata S,
Saito M, Kakizaki H, Nakayama Y, Matsusita T, Furuichi I, Sasazaki
Y, et al: Venous thromboembolism after total joint arthroplasty:
results from a Japanese multicenter cohort study. Arthritis Res
Ther. 16:R1542014. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liberati A, Altman DG, Tetzlaff J, Mulrow
C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J
and Moher D: The PRISMA statement for reporting systematic reviews
and meta-analyses of studies that evaluate health care
interventions: explanation and elaboration. Ann Intern Med.
151:W65–94. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Higgins JPT and Green S: Cochrane Handbook
for Systematic Reviews of Interventions Version 5.1.0 (updated
March 2011). The Cochrane Collaboration. 2011.Available from.
https://www.cochrane-handbook.org
|
|
17
|
Higgins JP, Thompson SG, Deeks JJ and
Altman DG: Measuring inconsistency in meta-analyses. BMJ.
327:557–560. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Turpie AG, Bauer KA, Eriksson BI and
Lassen MR: Fondaparinux vs enoxaparin for the prevention of venous
thromboembolism in major orthopedic surgery: a meta-analysis of 4
randomized double-blind studies. Arch Intern Med. 162:1833–1840.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Angchaisuksiri P: Venous thromboembolism
in Asia - an unrecognised and under-treated problem? Thromb
Haemost. 106:585–590. 2011. View Article : Google Scholar : PubMed/NCBI
|
